RedHill Biopharma
(NASDAQ) RDHL
RedHill Biopharma Financials at a Glance
Market Cap
$4.36M
Revenue (TTM)
$9.55M
Net Income (TTM)
-$9.31M
EPS (TTM)
$0.00
P/E Ratio
-0.01
Dividend
$0.00
Beta (Volatility)
1.25 (Average)
Dividend
$0.00
Beta (Volatility)
1.25 (Average)
Price
$0.83
Volume
161,589.908
Open
$0.83
Price
$0.83
Volume
161,589.908
Open
$0.83
Previous Close
$0.84
Daily Range
$0.81 - $0.87
52-Week Range
$0.71 - $3.31
Estimated Earnings Date
Aug 20, 2026
Dividend
$0.00
Beta (Volatility)
1.25 (Average)
Price
$0.83
Volume
161,589.908
Open
$0.83
Previous Close
$0.84
Daily Range
$0.81 - $0.87
52-Week Range
$0.71 - $3.31
Estimated Earnings Date
Aug 20, 2026
RDHL News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout RedHill Biopharma
Industry
Pharmaceuticals
Sector
Health CareEmployees
13
CEO
Dror Ben-Asher
Website
www.redhillbio.comHeadquarters
Tel Aviv, 6473921, IL
RDHL Financials
Key Financial Metrics (TTM)
Gross Margin
63%
Operating Margin
-1%
Net Income Margin
-99%
Return on Equity
0%
Return on Capital
-1%
Return on Assets
-27%
Earnings Yield
-100.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$4.36M
Shares Outstanding
5.19M
Volume
161.59K
Avg. Volume
203.15K
Financials (TTM)
Gross Profit
$286.00K
Operating Income
-$7.91M
EBITDA
-$7.65M
Operating Cash Flow
-$9.65M
Capital Expenditure
-$5.00K
Free Cash Flow
-$9.66M
Cash & ST Invst.
$3.97M
Total Debt
$1.07M
RedHill Biopharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.04M
+58.6%
Gross Profit
$1.24M
+111.6%
Gross Margin
60.60%
N/A
Market Cap
$4.36M
N/A
Market Cap/Employee
$124.59K
N/A
Employees
35
N/A
Net Income
-$2.07M
-33.8%
EBITDA
-$2.11M
+47.6%
Quarterly Fundamentals
Total Cash
$3.97M
-14.0%
Total Debt
$1.07M
+200.6%
Accounts Receivable
$2.48M
-2.4%
Inventory
$0.00
-100.0%
Long Term Debt
$900.00K
+29900.0%
Short Term Debt
$170.00K
-51.8%
Return on Assets
-26.53%
N/A
Return on Invested Capital
-1.22%
N/A
Free Cash Flow
-$2.51M
+18.9%
Operating Cash Flow
-$2.51M
+18.9%